ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 90

$1.08M Total Retail Price of All Prescriptions

Rank: 1 out of 90

337 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 337 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 337 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 12,279 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $138 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
NEXIUM 528 516 1 17
FUROSEMIDE 426 418 2 13
LIDODERM 399 388 3 29
ATORVASTATIN CALCIUM 290 284 4 25
LEVOTHYROXINE SODIUM 266 266 5 16
SIMVASTATIN 262 257 6 11
AMLODIPINE BESYLATE 252 242 7 10
LOVAZA 236 227 8 44
METOPROLOL SUCCINATE 235 235 9 32
MECLIZINE HCL 231 231 10 45
METFORMIN HCL 218 218 11 19
ACETAMINOPHEN-CODEINE 208 187 S3 12 34
VOLTAREN 197 196 13 37
ATELVIA 196 193 14 50
VYTORIN 176 176 15 51
ATENOLOL 176 165 15 42
LISINOPRIL 176 172 15 12
DIOVAN 172 159 18 52
DEXILANT 162 161 19 56
CRESTOR 149 139 20 43
ALLOPURINOL 136 136 21 6
METOPROLOL TARTRATE 133 131 22 23
TRAMADOL HCL 132 132 23 4
HYDROCHLOROTHIAZIDE 123 108 24 24
FLUTICASONE PROPIONATE 116 107 25 71
POTASSIUM CHLORIDE 114 110 26 36
DIOVAN HCT 112 112 27 47
SINGULAIR 109 103 28 55
BENICAR HCT 108 107 29 73
ZETIA 107 107 30 74
COLCRYS 106 104 31 20
CLOPIDOGREL 101 98 32 49
RANITIDINE HCL 100 89 33 31
JANUMET 99 99 34 76
ZOLPIDEM TARTRATE 97 85 35 39
DONEPEZIL HCL 95 95 36 79
AZOR 90 90 37 81
LIPITOR 89 84 38 82
ADVAIR DISKUS 88 87 39 57
PANTOPRAZOLE SODIUM 86 81 40 59
BYSTOLIC 85 85 41 58
LANSOPRAZOLE 81 81 42 85
WARFARIN SODIUM 81 80 42 53
PREDNISONE 80 76 44 1
ESCITALOPRAM OXALATE 78 78 45 86
PLAVIX 78 76 45 62
ACTONEL 77 77 47 68
GLIMEPIRIDE 75 75 48 88
NITROGLYCERIN PATCH 73 73 49 90
LUNESTA 72 72 50 92
TAMSULOSIN HCL 71 71 51 93
OXYCODONE-ACETAMINOPHEN 67 58 S2 52 21
BENICAR 66 66 53 96
ACTOS 64 64 54 99
IBANDRONATE SODIUM 61 61 55 105
ISOSORBIDE MONONITRATE ER 60 55 56 65
AZITHROMYCIN 58 53 57 107
SPIRONOLACTONE 58 56 57 70
CARVEDILOL 58 52 57 45
TOPROL XL 57 57 60 109
NITROSTAT 57 57 60 109
DIGOXIN 55 51 62 113
AMLODIPINE BESYLATE-BENAZEPRIL 53 53 63 119
CYCLOBENZAPRINE HCL 53 45 R 63 22
OMEPRAZOLE 52 44 65 28
GENERLAC 50 50 66 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.